Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Moodys
Merck
Dow
McKesson
Express Scripts
Baxter

Last Updated: January 17, 2020

DrugPatentWatch Database Preview

THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER Drug Profile

Join the DrugPatentWatch Referral Program
Get access to a free drug patent landscape report or a free one-month subscription

« Back to Dashboard

Which patents cover Theophylline 0.32% And Dextrose 5% In Plastic Container, and when can generic versions of Theophylline 0.32% And Dextrose 5% In Plastic Container launch?

Theophylline 0.32% And Dextrose 5% In Plastic Container is a drug marketed by B Braun and is included in one NDA.

The generic ingredient in THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER is theophylline. There are thirty-six drug master file entries for this compound. Fourteen suppliers are listed for this compound. Additional details are available on the theophylline profile page.

US ANDA Litigation and Generic Entry Outlook for Theophylline 0.32% And Dextrose 5% In Plastic Container

  Start Trial

A generic version of THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER was approved as theophylline by RHODES PHARMS on January 17th, 2020.

Summary for THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug patent expirations by year for THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER
Recent Clinical Trials for THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Johns Hopkins UniversityPhase 3
Beni-Suef UniversityPhase 1
Genentech, Inc.Phase 2

See all THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER clinical trials

Pharmacology for THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER
Drug ClassMethylxanthine

US Patents and Regulatory Information for THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
B Braun THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER theophylline INJECTABLE;INJECTION 019826-006 Aug 14, 1992 RX Yes Yes   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Express Scripts
Mallinckrodt
Colorcon
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.